Two Sigma Advisers
NGNE icon

Two Sigma Advisers’s Neurogene NGNE Stock Holding History

Two Sigma Advisers’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-8,470
Closed -$134K – 2595
2023
Q3 		$134K Sell
8,470
-755
-8% -$11.1K ﹤0.01% 2168
2023
Q2 		$153K Sell
9,225
-2,485
-21% -$40.7K ﹤0.01% 2140
2023
Q1 		$164K Sell
11,710
-805
-6% -$9.44K ﹤0.01% 2308
2022
Q4 		$127K Sell
12,515
-7,185
-36% -$74.2K ﹤0.01% 2265
2022
Q3 		$252K Buy
19,700
+320
+2% +$6.53K ﹤0.01% 2126
2022
Q2 		$399K Buy
19,380
+4,930
+34% +$120K ﹤0.01% 2023
2022
Q1 		$543K Buy
14,450
+2,715
+23% +$158K ﹤0.01% 1948
2021
Q4 		$1.13M Buy
11,735
+3,005
+34% +$366K ﹤0.01% 1504
2021
Q3 		$1.26M Buy
8,730
+5,745
+192% +$880K ﹤0.01% 1505
2021
Q2 		$551K Sell
2,985
-1,030
-26% -$228K ﹤0.01% 1909
2021
Q1 		$988K Sell
4,015
-2,640
-40% -$675K ﹤0.01% 1659
2020
Q4 		$1.88M Buy
6,655
+2,670
+67% +$652K 0.01% 1299
2020
Q3 		$956K Buy
3,985
+2,050
+106% +$497K ﹤0.01% 1519
2020
Q2 		$642K Buy
1,935
+940
+94% +$245K ﹤0.01% 1779
2020
Q1 		$226K Sell
995
-345
-26% -$71K ﹤0.01% 2125
2019
Q4 		$330K Sell
1,340
-580
-30% -$57.8K ﹤0.01% 2036
2019
Q3 		$109K Sell
1,920
-10
-0.5% -$610 ﹤0.01% 2107
2019
Q2 		$91K Hold
1,930
– – ﹤0.01% 2220
2019
Q1 		$104K Buy
1,930
+215
+13% +$10.9K ﹤0.01% 2187
2018
Q4 		$74K Buy
1,715
+1,040
+154% +$50.7K ﹤0.01% 2246
2018
Q3 		$40K Buy
+675
New +$39.8K ﹤0.01% 2186

Other funds holding NGNE

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Two Sigma Advisers's NGNE Position: Q4 2023 in Review

Two Sigma Advisers sold out of Neurogene (NGNE) in Q4 2023, closing a stake of 8,470 shares — an estimated $134K sold.

Two Sigma Advisers first reported a position in NGNE in Q3 2018 and held it in 21 quarters. The position peaked at $1.88M in Q4 2020. 35 funds tracked by Wall St. Rank hold NGNE as of Q4 2023.

  • Two Sigma Advisers reported no remaining Neurogene position as of Q4 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 8,470 Neurogene shares in Q4 2023, an estimated $134K.
  • Two Sigma Advisers first reported a position in Neurogene in Q3 2018 and held it in 21 quarters.
  • Two Sigma Advisers's Neurogene position peaked at $1.88M in Q4 2020.
  • 35 funds tracked by Wall St. Rank held Neurogene as of Q4 2023.

Based on Two Sigma Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.